Citation Impact
Citing Papers
A Comparison of Rate Control and Rhythm Control in Patients with Atrial Fibrillation
2002 Standout
Guidelines for Management of Ischaemic Stroke and Transient Ischaemic Attack 2008
2008 Standout
Effect of Clopidogrel Added to Aspirin in Patients with Atrial Fibrillation
2009 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
2015 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
Angiographic and clinical characteristics of patients with unstable angina showing an ECG pattern indicating critical narrowing of the proximal LAD coronary artery
1989
Assessment of Diastolic Function of the Heart: Background and Current Applications of Doppler Echocardiography. Part II. Clinical Studies
1989
Atrial stunning: Determinants and cellular mechanisms
2003
Temporal dependence of the return of atrial mechanical function on the mode of cardioversion of atrial fibrillation to sinus rhythm
1995
Echocardiographic Evaluation of Pericardial Effusion and Cardiac Tamponade
2017
Fourth Universal Definition of Myocardial Infarction (2018)
2018 Standout
Elevated D-dimer level is an independent risk factor for cardiovascular death in out-patients with symptoms compatible with heart failure
2004 StandoutNobel
A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation
2010 Standout
Transesophageal echocardiography before and during direct current cardioversion of atrial fibrillation: Evidence for “atrial stunning” as a mechanism of thromboembolic complications
1994
Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach
2009 Standout
Coronary plaque rupture in patients with myocardial infarction after noncardiac surgery: Frequent and dangerous
2012
Atrial ejection force: A noninvasive assessment of atrial systolic function
1993
Left Atrial Size
2006
Recommendations for Chamber Quantification: A Report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, Developed in Conjunction with the European Association of Echocardiography, a Branch of the European Society of Cardiology
2005 Standout
Oral Anticoagulant Therapy
2012 Standout
Therapeutic applications of compounds in the Magnolia family
2011 Standout
Recommendations for quantification of Doppler echocardiography: A report from the Doppler quantification task force of the nomenclature and standards committee of the American Society of Echocardiography
2002 Standout
Atrial Electrophysiologic Remodeling: Another Vicious Circle?
1998
American Society of Echocardiography Clinical Recommendations for Multimodality Cardiovascular Imaging of Patients with Pericardial Disease
2013 Standout
Cardiac Tamponade: Characteristic Doppler Observations
1989
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
2011 Standout
Right atrial compression in postoperative cardiac patients: Detection by transesophageal echocardiography
1990
Plasma von Willebrand factor, soluble thrombomodulin, and fibrin D-dimer concentrations in acute onset non-rheumatic atrial fibrillation
2004
GRADE guidelines: 3. Rating the quality of evidence
2011 Standout
Executive Summary
2012 Standout
Impaired left atrial mechanical function after cardioversion: Relation to the duration of atrial fibrillation
1994
Changes in Ultrastructural Calcium Distribution in Goat Atria During Atrial Fibrillation
2000
Timing of thromboembolic events after electical cardioversion of atrial fibrillation or flutter: a retrospective analysis
1998
Dabigatran versus Warfarin in Patients with Atrial Fibrillation
2009 Standout
Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
2015 Standout
Clinical Variables Affecting Recovery of Left Atrial Mechanical Function After Cardioversion From Atrial Fibrillation
1997
Antithrombotic Therapy in Atrial Fibrillation
2004
A Comparison of Rate Control and Rhythm Control in Patients with Recurrent Persistent Atrial Fibrillation
2002 Standout
High-Risk Coronary Atheroma
2013
Electrical, contractile and structural remodeling during atrial fibrillation
2002 Standout
Delayed rhythm control of atrial fibrillation may be a cause of failure to prevent recurrences: reasons for change to active antiarrhythmic treatment at the time of the first detected episode
2007
Extensive development of vulnerable plaques as a pan-coronary process in patients with myocardial infarction: an angioscopic study
2001
Efficacy and Safety of Apixaban in Patients After Cardioversion for Atrial Fibrillation
2013
Guidelines for Performing a Comprehensive Transthoracic Echocardiographic Examination in Adults: Recommendations from the American Society of Echocardiography
2018 Standout
Doppler Tissue Imaging: A Noninvasive Technique for Evaluation of Left Ventricular Relaxation and Estimation of Filling Pressures
1997 Standout
Percutaneous Transluminal Coronary Angioplasty
1994
Left atrial appendage “stunning” after spontaneous conversion of atrial fibrillation demonstrated by transesophageal Doppler echocardiography
1995
Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary Syndromes
2004 Standout
Triggering of cardiac events by sexual activity: findings from a case–crossover analysis
2000
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association
2017 Standout
Antithrombotic Therapy in Atrial Fibrillation
2001
Effects of the oral, direct factor Xa inhibitor rivaroxaban on commonly used coagulation assays
2010 StandoutNobel
Atrial Fibrillation
2001
Antithrombotic Therapy for Atrial Fibrillation
2012
Spontaneous Initiation of Atrial Fibrillation by Ectopic Beats Originating in the Pulmonary Veins
1998 Standout
Role of Orally Available Antagonists of Factor Xa in the Treatment and Prevention of Thromboembolic Disease: Focus on Rivaroxaban
2010
Implications of echocardiographically assisted diagnosis of pericardial tamponade in contemporary medical patients: Detection before hemodynamic embarrassment
1991
Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited
2009 Standout
Antithrombotic Therapy in Atrial Fibrillation
2008
Recovery of atrial function after atrial compartment operation for chronic atrial fibrillation in mitral valve disease
1994
Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography
2009 Standout
2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis
2016 Standout
2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
2011
2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
2011
Inflammation as a Risk Factor for Atrial Fibrillation
2003 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2019 Standout
Guidelines on the Diagnosis and Management of Pericardial Diseases Executive SummaryThe Task Force on the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology
2004 Standout
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
2011 Standout
Plasma fibrinogen and fibrin D-dimer in patients with atrial fibrillation: effects of cardioversion to sinus rhythm
1995
Guidelines for the Primary Prevention of Stroke
2014 Standout
Left ventricular diastolic collapse. An echocardiographic sign of regional cardiac tamponade.
1991
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons
2019 Standout
Mechanisms of Plaque Formation and Rupture
2014 Standout
Effects of aging on left atrial reservoir, conduit, and booster pump function: a multi-institution acoustic quantification study
2001
Platelet Glycoprotein IIb/IIIa Receptor Blockade and Low-Dose Heparin during Percutaneous Coronary Revascularization
1997 Standout
Prevention and Treatment of Thrombosis in Pediatric and Congenital Heart Disease
2013
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Fourth Universal Definition of Myocardial Infarction (2018)
2018 Standout
Color Flow Doppler Observations on Mitral Valve Flow in Tamponade
1991
Echocardiographic Doppler evaluation of left ventricular diastolic function. Physics and physiology.
1991
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation—Executive Summary
2006
Fourth universal definition of myocardial infarction (2018)
2018 Standout
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
2006
Antithrombotic Therapy in Atrial Fibrillation
1992
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2008 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack
2010 Standout
Atrial Contractile Dysfunction After Short-term Atrial Fibrillation Is Reduced by Verapamil but Increased by BAY K8644
1996
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
Cellular Mechanisms of Atrial Contractile Dysfunction Caused by Sustained Atrial Tachycardia
1998
Role of the Na+/H+Exchanger in Short-Term Atrial Electrophysiological Remodeling
2000
Works of David E. Leeman being referenced
Doppler echocardiography in cardiac tamponade: Exaggerated respiratory variation in transvalvular blood flow velocity integrals
1988
Angioscopic Assessment of Coronary Lesions Underlying Thrombus
1997
Pulsed Doppler evaluation of atrial mechanical function after electrical cardioversion of atrial fibrillation
1989
Angioscopy of Culprit Coronary Lesions in Unstable Angina Pectoris and Correlation of Clinical Presentation With Plaque Morphology
1998
Use of percutaneous transluminal coronary angioplasty and bypass surgery despite improved medical therapy for unstable angina pectoris
1988
Plaque disruption and thrombus in Ambrose’s angiographic coronary lesion types
2003